Delivery Order SPE2DB22D3004-SPE2DB24FQD52
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $9,269.10, is for the delivery of 180 tablets of the medication Meloxicam 15 mg. The contract is a Firm Fixed Price Delivery Order with an ultimate completion date of June 17, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,218.78 firm fixed-price delivery order is for the supply of 100 units of the medication Meloxicam 15 mg Tablet. The contract has a completion date of May 21, 2025 and is not set aside for any particular business classification. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery...
- This federal contract award, valued at $44,430.73, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order for 4,566,211,113 tablets of the medication Meloxicam 15 mg, with a firm fixed price and an ultimate completion date of October 28, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award is for the delivery of 4,566,281,392 units of 15 mg Meloxicam tablets over a period ending on October 31, 2024. The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Firm Fixed Price Delivery Order with a ceiling value of $39,305.93. This award is associated with a larger Indefinite Delivery Contract (IDC) held by...
- This federal contract award is for the delivery of Meloxicam 15 mg tablets, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., for a ceiling value of $23,877.92. The contract is a Delivery Order with a Firm Fixed Price pricing type, and the ultimate completion date is May 1, 2024. The contract does not have a set-aside designation, indicating it was awarded through full and...
- This federal contract award, valued at $1,019.20, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award is for the delivery of 4555358604 - MELOXICAM 7.5 MG TABLET 1000S, and has a completion date of November 9, 2021. This delivery order contract is a firm fixed-price arrangement, and there is no set-aside designation mentioned. Amerisourcebergen Drug Corp is a subsidiary of Cencora,...
- This federal contract award, with an ID of SPE2DB22D3004|SPE2DB24FQE38, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $8,136.80, is for the delivery of Meloxicam 7.5 mg tablets over a period ending on May 1, 2024. This is a firm fixed-price delivery order contract, with no set-aside designation. Amerisourcebergen Drug Corp, the prime contractor, is a major pharmaceutical distributor that specializes in...
- This federal contract award, with an ID of SPE2DB22D3004|SPE2DB24FPJ88, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 180 tablets of the medication Meloxicam 15 mg, with a ceiling value of $4,978.00 and a completion date of February 21, 2024. Amerisourcebergen Drug Corp is the prime contractor on this contract, which is a delivery order under a larger...
- The Defense Logistics Agency awarded a $1,964.93 delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Meloxicam 15 mg tablets in unit-dose packaging (100-count). The contract, which is a firm fixed-price delivery order with no set-aside designation, is scheduled for completion by December 8, 2025. AmerisourceBergen will perform this work at its corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,951.91, is a delivery order for pharmaceutical and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. Amerisourcebergen, a subsidiary of the parent company Cencora, Inc., holds a significant Indefinite Delivery Contract...
- SPE2DB22D3004Indefinite Delivery Contract
- SPE2DB22D3004-SPE2DB24FQD52Delivery Order
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $5,954.53, to provide Meloxicam 7.5 mg tablets to support military healthcare programs. The award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. This IDC serves as the primary vehicle for Amerisourcebergen to deliver a comprehensive range of pharmaceutical products and medical supplies to the DLA, supporting the healthcare needs of military personnel, veterans, and other federal beneficiaries. The contract covers critical medical commodities across multiple therapeutic areas, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $6.0k | 4/26/24 |